Anastrozole vs Tamoxifen: Similar Outcomes, Different Toxicities
Dec 9, 2020 · In contrast, patients who received anastrozole had a significantly higher odds of having a fracture (OR, 1.34; 95% CI, 1.06-1.70; P =.013) or transient ischemic attack (OR, 3.10; 95% CI, 1.07-10. ...
Hypercalcemia in Cancer: Causes, Symptoms, and Management
Nov 17, 2023 · Patients with hypercalcemia may present with kidney stones; chronic renal insufficiency; bone pain; excessive urine production; gastrointestinal symptoms such as nausea, vomiting, and constipation ...
Positive Anti-Nuclear Antibody (ANA) Test - Cancer Therapy Advisor
Jan 17, 2019 · Suggested Additional Lab Testing. For follow-up from a positive ANA test: For SLE: anti Ds DNA, anti-SS-A (Ro), anti-SS-B (La), anti-U1 RNP, anti-Sm, and follow-up with serial anti-DS DNA. For ...
Breast Cancer Awareness Month: Its History, Impact, and the Pink …
Sep 18, 2023 · National Breast Cancer Awareness Month began as a weeklong event in 1985. It was organized by the ACS and the pharmaceutical division of Imperial Chemical Industries, which later became part of ...
Liver Mass Symptoms and Evaluation - Cancer Therapy Advisor
Jan 17, 2019 · When symptoms occur, they are the same as those of simple cysts and can include: Abdominal bloating and mass formation from deforming the liver capsule. Jaundice from compression of the biliary ...
Cancer Patients and Vaccines: Who and When to Vaccinate
Mar 28, 2024 · Patients should typically receive vaccines 2-4 weeks before cancer treatment, but non-live vaccines can be given during or after certain treatments. The American Society of Clinical Oncology (ASCO ...
Extended Letrozole Prolonged Survival in Postmenopausal Patients …
Oct 18, 2021 · Extended treatment with letrozole significantly improved survival in postmenopausal patients with early-stage breast cancer, according to results of a phase 3 trial published in The Lancet ...
Elevated WBC Count - Cancer Therapy Advisor
Jan 17, 2019 · Monocyte count is usually increased along with an elevated lymphocyte count. Eosinophils can become increased in patients with allergic disorders, asthma, certain parasitic, and dermatologic ...
On-Treatment Ki-67: A Promising Prognostic Marker for Early …
Jul 12, 2021 · Major Findings in High-Risk Patients. In both the ET-alone and chemotherapy-ET trials, higher recurrence score, nodal status, tumor size, higher baseline Ki-67, and higher post-ET Ki-67 were ...
Dostarlimab Plus Niraparib Up PFS in Advanced, Recurrent …
Mar 17, 2024 · The median PFS was not reached in the dostarlimab-niraparib arm and was 7.9 months in the chemotherapy-alone arm (HR, 0.48; 95% CI, 0.24-0.96; P =.0174). The 12-month PFS rates were 64.4% and 40.8 ...